Cargando…

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019

BACKGROUND: Inappropriate empiric antimicrobial treatment (IET) contributes to worsened outcomes. While IET’s differential impact across types of nosocomial pneumonia (NP: non-ventilated [nvHABP], ventilated [vHABP] hospital-acquired and ventilator-associated [VABP] bacterial pneumonia) is establish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D., Nathanson, Brian H., Puzniak, Laura A., Dillon, Ryan J., Shorr, Andrew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533487/ https://www.ncbi.nlm.nih.gov/pubmed/36199012 http://dx.doi.org/10.1186/s12879-022-07755-y

Ejemplares similares

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

1460. Imipenem/Cilastatin (IMI)/Relebactam (REL) in Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia (HABP/VABP): Subgroup Analyses of Critically Ill Patients in the RESTORE-IMI 2 Trial
por: Chen, Luke F, et al.
Publicado: (2020)

1230. Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)/Relebactam (REL) Versus Piperacillin/Tazobactam (PIP/TAZ)
por: Losada, Maria C, et al.
Publicado: (2020)

Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain
por: Ferrer, Ricard, et al.
Publicado: (2021)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Analisi di costo-utilità di ceftolozano/tazobactam rispetto a meropenem in pazienti con polmonite acquisita in ospedale (HABP) o polmonite associata a ventilazione meccanica (VABP)
por: Mennini, Francesco Saverio, et al.
Publicado: (2022)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

HABP2 G534E Variant in Papillary Thyroid Carcinoma
por: Tomsic, Jerneja, et al.
Publicado: (2016)

HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer
por: Weeks, Alexia L., et al.
Publicado: (2016)

Diagnostic and prognostic value of HABP2 as a novel biomarker for endometrial cancer
por: Jiang, Ying, et al.
Publicado: (2020)

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning
por: Zilberberg, Marya D, et al.
Publicado: (2008)

HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression
por: Mirzapoiazova, Tamara, et al.
Publicado: (2015)

Hyaluronan–binding protein 2 (HABP2) gene variation in women with recurrent miscarriage
por: Husseini-Akram, Frida, et al.
Publicado: (2018)

Elevated HABP1 protein expression correlates with progression and poor survival in patients with gastric cancer
por: Gao, Hongyu, et al.
Publicado: (2016)

The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics
por: Bohórquez, Mabel E, et al.
Publicado: (2016)

HABP2 p.G534E variant in patients with family history of thyroid and breast cancer
por: Pinheiro, Maisa, et al.
Publicado: (2017)

Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2021)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Intracellular hyaluronic acid-binding protein 4 (HABP4): a candidate tumor suppressor in colorectal cancer
por: Melo-Hanchuk, Talita Diniz, et al.
Publicado: (2020)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2008)

The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population
por: Kowalik, Artur, et al.
Publicado: (2017)

Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions
por: Colleti, Carolina, et al.
Publicado: (2019)

Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4
por: Liu, Yujie, et al.
Publicado: (2021)

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2010)

Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer
por: Gerhard, Glenn S., et al.
Publicado: (2017)

gC1qR/HABP1/p32 Is a Potential New Therapeutic Target Against Mesothelioma
por: Peerschke, Ellinor, et al.
Publicado: (2020)

Genetic Association and Gene-gene interaction of HAS2, HABP1 and HYAL3 Implicate Hyaluronan Metabolic Genes in Glaucomatous Neurodegeneration
por: Basu, Kaustuv, et al.
Publicado: (2012)

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2009)

Ventilation and Ventilators
Publicado: (1894)

2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study
por: Zilberberg, Marya, et al.
Publicado: (2019)

Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis
por: Kim, Beom-Chan, et al.
Publicado: (2016)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
por: Swanson, Joseph M., et al.
Publicado: (2013)

Non-ventilator associated hospital acquired pneumonia (NV-HAP) risk among hospitalized veterans before and during the COVID-19 pandemic
por: Carey, Evan, et al.
Publicado: (2023)

Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort
por: Galerneau, Louis-Marie, et al.
Publicado: (2023)

Plasmodium falciparum Uses gC1qR/HABP1/p32 as a Receptor to Bind to Vascular Endothelium and for Platelet-Mediated Clumping
por: Biswas, Anup Kumar, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3bchmaeboks3mabm09u3ob0iag